Phase II study of oral S-1 plus cisplatin with concurrent radiotherapy for locally advanced non-small cell lung cancer
Phase 2
- Conditions
- ocally Advanced Non-Small Cell Lung Cancer
- Registration Number
- JPRN-UMIN000001745
- Lead Sponsor
- Gunma University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Not provided
Exclusion Criteria
Patients were excluded if they had malignant pleural or pericardial effusion, active double cancer, a concomitant serious illness, such as uncontrolled angina pectoris, myocardial infarction in the previous 3 months, heart failure, uncontrolled diabetes mellitus, uncontrolled hypertension, interstitial pneumonia or lung disease, infection or other diseases contraindicating chemotherapy or radiotherapy, pregnancy, or breast-feeding. Judging of inappropriate condition for this study by physian
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Response rate
- Secondary Outcome Measures
Name Time Method Adverse events, overall survival, progression-free survival, safty